Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

KalVista Pharmaceuticals (KALV) Revenue (2016 - 2020)

Historic Revenue for KalVista Pharmaceuticals (KALV) over the last 7 years, with Q2 2020 value amounting to $3.8 million.

  • KalVista Pharmaceuticals' Revenue rose 3069.04% to $3.8 million in Q2 2020 from the same period last year, while for Jan 2021 it was $3.8 million, marking a year-over-year decrease of 6757.12%. This contributed to the annual value of -$5.8 million for FY2025, which is 11157.0% down from last year.
  • Per KalVista Pharmaceuticals' latest filing, its Revenue stood at $3.8 million for Q2 2020, which was up 3069.04% from $1.6 million recorded in Q1 2020.
  • KalVista Pharmaceuticals' 5-year Revenue high stood at $5.6 million for Q4 2018, and its period low was $7000.0 during Q1 2016.
  • In the last 5 years, KalVista Pharmaceuticals' Revenue had a median value of $2.3 million in 2018 and averaged $2.3 million.
  • Its Revenue has fluctuated over the past 5 years, first plummeted by 9015.38% in 2017, then skyrocketed by 414561.4% in 2018.
  • Over the past 5 years, KalVista Pharmaceuticals' Revenue (Quarter) stood at $197000.0 in 2016, then soared by 472.08% to $1.1 million in 2017, then soared by 396.18% to $5.6 million in 2018, then dropped by 29.9% to $3.9 million in 2019, then dropped by 2.45% to $3.8 million in 2020.
  • Its Revenue was $3.8 million in Q2 2020, compared to $1.6 million in Q1 2020 and $3.9 million in Q4 2019.